z-logo
open-access-imgOpen Access
Hypofractionated Radiation with concurrent Cisplatin plus Erlotinib in locally advanced squamous cell carcinomas of head and neck: A Feasibility Phase II Study of a Single Institute
Author(s) -
Manirathinam Ramalingam
Publication year - 2017
Publication title -
journal of medical science and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-0450
pISSN - 2347-176X
DOI - 10.18535/jmscr/v5i12.68
Subject(s) - medicine , erlotinib , cisplatin , oncology , head and neck , head and neck squamous cell carcinoma , head and neck cancer , radiation therapy , chemotherapy , surgery , cancer , epidermal growth factor receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom